Clinical Trials Sponsored by Novus Scientific

Total 1992 results

Novus Scientific

Completed

Safety and Performance Study of TIGR Matrix Surgical Mesh in Inguinal Hernia Repair

Inguinal Hernia

Sweden
University Hospital, Ghent
Novus Scientific

Active, not recruiting

Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh. (TIGR)

Primary and Secondary Ventral Hernia

United Kingdom, Belgium, Denmark, Poland, Spain
Novus Therapeutics, Inc

Completed

Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers

Healthy Adult Volunteers

United States
Novus Therapeutics, Inc

Completed

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults

Healthy Adults

Germany
Novus Therapeutics, Inc

Completed

Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media

Acute Otitis Media

United States
Novus Therapeutics, Inc

Completed

A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months

Acute Otitis Media

United States
NewAmsterdam Pharma
Novum

Recruiting

Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

Healthy Volunteers

United States
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Terminated

A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa

Otitis Externa

United States, Puerto Rico
Amneal Pharmaceuticals, LLC
Novum Pharmaceutical Research Services

Completed

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Anchen Pharmaceuticals, Inc
Novum Pharmaceutical Research Services

Completed

Evaluation of Clinical Equivalence Between Two Lubiprostone Products

Chronic Idiopathic Constipation

United States
Anchen Pharmaceuticals, Inc
Novum Pharmaceutical Research Services

Completed

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

Osteo Arthritis of the Knee

United States
Jenscare Scientific

Not yet recruiting

A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System

Mitral Valve Regurgitation | Degenerative Mitral Valve Disease
Semler Scientific

Completed

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods

D012039 | D001775

United States
Jenscare Scientific

Recruiting

A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement

Tricuspid Regurgitation

France
Hero Scientific

Recruiting

Detection of Group A β-Hemolytic Streptococci in Oral Samples

Group A β-Hemolytic Streptococci

Israel
Jenscare Scientific

Enrolling by invitation

The JensClip Transcatheter Valve Repair System for Treating Functional Mitral Regurgitation

Functional Mitral Regurgitation

China
MD Scientific

Terminated

Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease (BOSS)

Contrast Induced Kidney Injury.

United States
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Completed

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Terminated

Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes

Otitis Media in Patients With Tympanostomy Tubes

United States
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Completed

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

To Determine the Bioequivalence Study Under Fasting
Encube Ethicals Pvt. Ltd.
Novum Pharmaceutical Research Services

Completed

Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies

Scabies

United States, El Salvador, Puerto Rico
Dr. Reddy's Laboratories Limited
Novum Pharmaceutical Research Services

Completed

A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies

Scabies

United States, El Salvador, Panama
Sun Pharmaceutical Industries Limited
Novum Pharmaceutical Research Services

Withdrawn

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Plaque Psoriasis
Sun Pharmaceutical Industries Limited
Novum Pharmaceutical Research Services

Terminated

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Encube Ethicals Pvt. Ltd.
Novum Pharmaceutical Research Services

Completed

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

Actinic Keratoses

United States
Circa Scientific, Inc.

Recruiting

Epicardial Access Study With Rook (EASY-R)

Arrythmia

Czechia
Boston Scientific Corporation

Not yet recruiting

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) (VITALYST EFS)

Heart Disease, Coronary | High-risk Percutaneous Coronary Intervention

United States, Sweden
Boston Scientific Corporation

Recruiting

MANTIS Endoscopic Clipping Study

Endoscopy | Hemostasis | Perforation Colon | Feeding Tube Complication

United States, India, Hong Kong, Canada, Japan, China
Boston Scientific Corporation

Recruiting

Watchman FLX Pro CT Pilot Study

Non-valvular Atrial Fibrillation (AF)

Denmark
Boston Scientific Corporation

Recruiting

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)

Glioblastoma Multiforme | Recurrent Glioblastoma

United States
Boston Scientific Corporation

Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

Peripheral Vascular Diseases

United States, Australia, Taiwan, Canada, Thailand, Austria, Germany, Spain, France, China, Poland
Boston Scientific Corporation

Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study (RAPID)

Pain, Chronic

United States, United Kingdom, Germany, Belgium, Italy, Netherlands
Boston Scientific Corporation

Recruiting

Vercise™ DBS Dystonia Prospective Study

Dystonia

Germany, United Kingdom, Italy, Belgium, Hungary, Israel, Netherlands, Poland, Russian Federation, Spain, Korea, Republic of
Boston Scientific Corporation

Recruiting

RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain (RELIEF)

Pain

United States, Spain, Germany, United Kingdom, Belgium, Colombia, Argentina, Australia, Denmark, Israel, Italy, Japan, Canada, Netherlands, Switzerland, Sweden
Boston Scientific Corporation

Completed

Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)

Sudden Cardiac Death

United States, Spain, Korea, Republic of, United Kingdom, Canada, Japan, Austria, Italy
Boston Scientific Corporation

Active, not recruiting

A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China

Cardiovascular Diseases

China
Boston Scientific Corporation

Completed

SpaceOAR System RWS in China

Localized T1-T2 Prostate Cancer

China
Boston Scientific Corporation

Active, not recruiting

Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) (NECTAR-HF)

Heart Failure | Congestive Heart Failure

Spain, Netherlands, Germany, Italy, United Kingdom, Belgium, Czechia, France
Boston Scientific Corporation

Completed

RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)

Atherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial Disease

United States, Belgium, Canada, Japan, Austria, New Zealand
Boston Scientific Corporation

Active, not recruiting

A RWS of the FARAPULSE in A Chinese Population With PAF

Paroxysmal Atrial Fibrillation

China
Boston Scientific Corporation

Active, not recruiting

POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART) (POLAR SMART)

Paroxysmal Atrial Fibrillation

Korea, Republic of, Japan
Boston Scientific Corporation

Active, not recruiting

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) (VERITAS)

Varicose Veins

United States
Boston Scientific Corporation

Active, not recruiting

An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients

Chinese Patients Treated With Agent DCB

Taiwan, Hong Kong, Singapore
Boston Scientific Corporation

Active, not recruiting

CHAMPION-AF Clinical Trial (CHAMPION-AF)

Stroke | Atrial Fibrillation | Bleeding

United States, Australia, Denmark, Canada, Israel, United Kingdom, France, Belgium, Netherlands, Japan, Germany, Switzerland, Italy, Poland, Saudi Arabia, Spain
Boston Scientific Corporation

Completed

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Hepatocellular Carcinoma

United States
Boston Scientific Corporation

Active, not recruiting

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

Stroke

United States, Denmark, Germany, Netherlands, United Kingdom, Belgium, Canada, Czechia, Italy
Boston Scientific Corporation

Active, not recruiting

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Denmark
Boston Scientific Corporation

Active, not recruiting

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation (OPTION)

Atrial Fibrillation

United States, Spain, Denmark, Australia, France, Germany, Italy, Poland, Belgium, Netherlands
Boston Scientific Corporation

Active, not recruiting

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation (ADVANTAGE AF)

Persistent Atrial Fibrillation

United States, Belgium, Canada, Spain
Boston Scientific Corporation

Completed

Multiple Cardiac Sensors for the Management of Heart Failure (MANAGE-HF)

Heart Failure, Congestive

United States, Germany, France

Clinical Trials Sponsored by Novus Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations